Earnings Call · Q3 FY2025·2025-11-04

Q3 25EPS +100.00%*·Rev n/aQ2 25EPS +63.64%·Rev n/aQ1 25EPS -11.11%·Rev n/aQ4 24EPS -98.70%·Rev n/a⚠ consensus missing

Mirum Pharmaceuticals, Inc. MIRM

Andrew McKibben — SVP of Strategic Finance and Investor Relations

Christopher Peetz — Chief Executive Officer

Peter Radovich — President and Chief Operating Officer

Joanne M. Quan — Chief Medical Officer

Eric Bjerkholt — Chief Financial Officer

−1.2%1d on move date−1.6% vs SPY3d−4.0%5d+0.5%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more MIRM calls or request research access.

More MIRM calls Browse calls Request research access